Shining a light on cancer

We are developing a multi-cancer platform powered by our Dxcover AI Engine, with first application in earlier diagnosis of brain tumors.

To be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.

Effective Early Detection of Pancreatic Cancer Using Infrared Spectroscopy

Study published in Cancers demonstrates how simple, minimally invasive and accurate approaches can represent a powerful aid in earlier...

Dxcover Launches Infrared Platform: Ground-breaking technology for faster sample analysis

Dublin, Ireland June 20, 2022 Dxcover Limited, a diagnostics company developing spectroscopic liquid biopsy technology for early...

Dxcover Presents Data on Benefits of Spectroscopic Liquid Biopsy at ASCO

Dxcover test could have a significant impact on early detection of cancer, vital for improved survival and quality of life Chicago,...